Miloš Marković

759 total citations
50 papers, 610 citations indexed

About

Miloš Marković is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Miloš Marković has authored 50 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Miloš Marković's work include SARS-CoV-2 and COVID-19 Research (10 papers), Multiple Sclerosis Research Studies (6 papers) and COVID-19 Clinical Research Studies (6 papers). Miloš Marković is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Multiple Sclerosis Research Studies (6 papers) and COVID-19 Clinical Research Studies (6 papers). Miloš Marković collaborates with scholars based in Serbia, Czechia and Germany. Miloš Marković's co-authors include Djordje Miljković, Vladimir Trajković, Zorica Ramić, Marija Mostarica Stojković, Dušan Popadić, Stanislava Stošić‐Grujičić, Tatjana Samardžić, Marija Mostarica‐Stojković, Mioljub Ristić and Vladimir Petrović and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of the Acoustical Society of America.

In The Last Decade

Miloš Marković

47 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miloš Marković Serbia 15 219 102 101 88 84 50 610
I. V. Kudryavtsev Russia 14 199 0.9× 62 0.6× 139 1.4× 207 2.4× 41 0.5× 129 765
Kiel M. Telesford United States 8 152 0.7× 79 0.8× 145 1.4× 361 4.1× 45 0.5× 15 562
Ai Harashima Japan 19 489 2.2× 107 1.0× 86 0.9× 444 5.0× 71 0.8× 39 1.4k
Majid Teymoori‐Rad Iran 11 180 0.8× 168 1.6× 198 2.0× 263 3.0× 19 0.2× 19 766
Ferenc Somogyvári Hungary 17 101 0.5× 59 0.6× 88 0.9× 252 2.9× 60 0.7× 60 909
Norinne Lacerda‐Queiroz Brazil 17 393 1.8× 34 0.3× 112 1.1× 167 1.9× 195 2.3× 28 826
Joo Chun Yoon South Korea 12 256 1.2× 48 0.5× 42 0.4× 255 2.9× 51 0.6× 19 984
Pennelope Blakely United States 13 125 0.6× 17 0.2× 96 1.0× 98 1.1× 71 0.8× 26 530
Najma Javed United States 16 205 0.9× 27 0.3× 43 0.4× 167 1.9× 35 0.4× 39 914
Jianling Li China 14 135 0.6× 223 2.2× 115 1.1× 278 3.2× 18 0.2× 64 945

Countries citing papers authored by Miloš Marković

Since Specialization
Citations

This map shows the geographic impact of Miloš Marković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miloš Marković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miloš Marković more than expected).

Fields of papers citing papers by Miloš Marković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miloš Marković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miloš Marković. The network helps show where Miloš Marković may publish in the future.

Co-authorship network of co-authors of Miloš Marković

This figure shows the co-authorship network connecting the top 25 collaborators of Miloš Marković. A scholar is included among the top collaborators of Miloš Marković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miloš Marković. Miloš Marković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mijač, Vera, et al.. (2023). Intestinal Colonization of Preterm Neonates with Carbapenem Resistant Enterobacteria at Hospital Discharge. Antibiotics. 12(2). 284–284. 12 indexed citations
2.
4.
Ristić, Mioljub, et al.. (2022). Predictors of vaccination against coronavirus disease 2019 in Serbia. Medicinski pregled. 75(3-4). 89–96.
5.
Petrović, Vladimir, et al.. (2022). Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia. PLoS ONE. 17(10). e0274674–e0274674. 3 indexed citations
6.
Petrović, Vladimir, Vladimir Vuković, Miloš Marković, & Mioljub Ristić. (2022). Early Effectiveness of Four SARS-CoV-2 Vaccines in Preventing COVID-19 among Adults Aged ≥60 Years in Vojvodina, Serbia. Vaccines. 10(3). 389–389. 14 indexed citations
7.
8.
Mihajlović, Goran, et al.. (2019). Immunological Aspects of Depressive Disorder - The Review. 25(1). 3–12. 1 indexed citations
9.
Mijač, Dragana, Vera Mijač, Vladimir Perović, et al.. (2018). MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease. PLoS ONE. 13(3). e0194536–e0194536. 19 indexed citations
10.
Marković, Miloš, et al.. (2016). Survivin and VEGF as novel biomarkers in diagnosis of endometriosis. SHILAP Revista de lepidopterología. 4 indexed citations
11.
Jin, Wenyu, Miloš Marković, & Liyun Pang. (2016). Multizone Soundfield Reproduction with Virtual Elevations Using a Linear Loudspeaker Array. Journal of the Audio Engineering Society. 1 indexed citations
12.
Dujmović, Irena, Miloš Marković, Šarlota Mesaroš, et al.. (2015). Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up. Journal of Neuroimmunology. 287. 64–70. 2 indexed citations
13.
Popadić, Dušan, et al.. (2012). Distinctive Frequencies of +874T/A IFN‐γ Gene Polymorphism in a Healthy Serbian Population. Clinical and Translational Science. 5(6). 461–463. 8 indexed citations
14.
Pravica, Vera, et al.. (2012). Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. Immunologic Research. 52(1-2). 42–52. 19 indexed citations
15.
Tulić, C., Miodrag Lazić, Dušan Popadić, et al.. (2011). The preoperative activity of Th1 and Th17 cytokine axes in prediction of sepsis after radical cystectomy. European Cytokine Network. 22(4). 169–174. 3 indexed citations
16.
Momčilović, Miljana, Željka Miljković, Dušan Popadić, et al.. (2008). Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells. BMC Immunology. 9(1). 47–47. 20 indexed citations
17.
Miljković, Djordje, Stanislava Stošić‐Grujičić, Miloš Marković, et al.. (2006). Strain difference in susceptibility to experimental autoimmune encephalomyelitis between Albino Oxford and Dark Agouti rats correlates with disparity in production of IL-17, but not nitric oxide. Journal of Neuroscience Research. 84(2). 379–388. 47 indexed citations
18.
Marković, Miloš, Nikola Ž. Knežević, Miljana Momčilović, et al.. (2005). [Pt(HPxSC)Cl3], a novel platinum(IV) compound with anticancer properties. European Journal of Pharmacology. 517(1-2). 28–34. 5 indexed citations
19.
Trajković, Vladimir, Stanislava Stošić‐Grujičić, Djordje Miljković, et al.. (2004). Astrocyte‐induced regulatory T cells mitigate CNS autoimmunity. Glia. 47(2). 168–179. 67 indexed citations
20.
Stošić‐Grujičić, Stanislava, Ana Savić-Radojević, Danijela Maksimović‐Ivanić, et al.. (2002). Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin. Journal of Neuroimmunology. 130(1-2). 66–77. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026